Rationale and design of a randomized trial of the dapagliflozin evaluation on atrial fibrillation patients followed Cox-Maze IV: the DETAIL-CMIV study

AIMS: Dapagliflozin has been widely used for the treatment of type 2 diabetes mellitus (T2DM) and heart failure (HF). However, data concerning the association between dapagliflozin and the recurrence of atrial fibrillation (AF), especially in patients following Cox-Maze IV (CMIV), are rare. We aim t...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Zhan, Osmanaj, Florian, Yang, Yunxiao, Hua, Kun, Yang, Xiubin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Trial Design
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655060/
https://www.ncbi.nlm.nih.gov/pubmed/37939825
http://dx.doi.org/10.1093/europace/euad333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655060/
https://www.ncbi.nlm.nih.gov/pubmed/37939825
http://dx.doi.org/10.1093/europace/euad333

Ejemplares similares